1-4 of 4
Eloisa Jantus-Lewintre
Close
Sort by
Journal Articles

Analysis of B-CLL Transcriptomic and Proteomic Profiles: Differences between Molecular Subgroups.

Eloisa Jantus Lewintre, MSc, Miguel Marin, Cristina Reinoso, PhD, David Montaner, Joaquín Dopazo, PhD, Juan Jose Calvete, PhD, Javier Garcia-Conde, PhD
Journal: Blood
Blood (2006) 108 (11): 2088.
https://doi.org/10.1182/blood.V108.11.2088.2088
Published: 2006
Journal Articles

Characterization of the Proteomic and Genomic Profiles of Chronic Lymphocytic Leukemia Patients with Distinct Clinical Prognosis According to the Mutational Status of the IgVH and BCL6 and Expression Level of CD38 and ZAP70.

Miguel Marin, Eloisa Jantus-Lewintre, Libia Sanz, Doctor in Biology, Angel Garcia-Martin, Doctor in Biology, Cristina Reinoso, Doctor in Biology, Isabel Benet, Medical Doctor, David Montaner, Juan M. Vaquerizas, Joaquin Dopazo, Doctor in Biology, Juan J. Calvete, Doctor in Biology, Javier Garcia-Conde
Journal: Blood
Blood (2005) 106 (11): 3272.
https://doi.org/10.1182/blood.V106.11.3272.3272
Published: 2005
Journal Articles

Influence of Different Complement Sources in Apoptosis of B-CLL Cells with Rituximab.

Elena Sarsotti, MSc, Eloisa Jantus-Lewintre, MSc, Maria J. Terol, MD, Isabel Benet, MD, Javier Garcia-Conde, MD
Journal: Blood
Blood (2004) 104 (11): 4782.
https://doi.org/10.1182/blood.V104.11.4782.4782
Published: 2004
Journal Articles

Treatment of B-CLL Cells with Bortezomib and Rituximab Reduces Cell Viability In Vitro..

Eloisa Jantus Lewintre, MSc, Elena Sarsotti, Msc, Maria Jose Terol, MD, Isabel Benet, MD, Jose A. Martinez-Climent, MD, Javier Garcia-Conde, MD
Journal: Blood
Blood (2004) 104 (11): 2798.
https://doi.org/10.1182/blood.V104.11.2798.2798
Published: 2004